Accueil   Diary - News   All news Novasep and Triclinic Labs enter a strategic alliance for solid-state chemistry services

Novasep and Triclinic Labs enter a strategic alliance for solid-state chemistry services

Novasep-logo-300dpi

Lyon, France, September 14, 2016 – Novasep, a leading supplier of services and technologies for the life sciences industry, today announces its partnership with Triclinic Labs, Inc., a US-based provider of contract pharmaceutical and fine chemical solid-state development services.

 

 

This is Novasep’s first partnership agreement focusing on early-stage, solid-state services. Those services will be in addition to Novasep’s existing, early-stage, active pharmaceutical ingredient (API) synthesis and purification services and made available to customers in North America as well as other regions.

 

 

The newly formed alliance between Novasep and Triclinic Labs will enable both parties to offer their customers a full API development service, ranging from first chemical synthesis to solid form optimization. Novasep’s services will be extended to include solid form screening, selection, development, characterization and analytical method development.

 

 

Read the press release